Morphological changes in tissues of organs in rats with arterial hypertension (SHR) with treatment of hypotensive medicines (with ramipril and candesartan) in combination with corvitin
DOI:
https://doi.org/10.15587/2519-4852.2020.197300Keywords:
Hypertension, candesartan, ramipril, CorvitinAbstract
To date, arterial hypertension (AH) is the most common cardiovascular disease, which is the most common cause of disability in the population due to high risk of developing complications, such as heart failure, coronary heart disease, stroke. The nature of the morphological manifestations of hypertensive disease depends on the duration and its severity, but hypertension triggers a cascade of pathological changes in the lung disease and is accompanied by disruption of the structure most sensitive to fluctuations in blood pressure organs (brain, heart, kidneys). The search for new drugs that not only reduce blood pressure but also have polytropic effects is constantly in progress. In the first place is cardioprotection, which is based on the principles of continuous monitoring of myocardial oxygenation and metabolism. Recently the attention of researchers attract bioflavonoids, namely Corvitin, which has antioxidant, prediabetics, anti-inflammatory properties. The question of influence Corwin in combination therapy with antihypertensive drugs in the treatment of hypertension has been insufficiently studied, that determines the relevance and aim of our study.
Materials and methods. The study was performed on hypertensive SHR rats, which spontaneously had hypertension. Rats were divided into groups. Experienced animal groups SHR were administered ramipril at a dose of 0.5 mg /kg, candesartan – 0.4mg /kg, and conducted combined therapy ramipril and corvitin, candesartan and corvitin. Corvitin – 50 mg /kg. Drugs were administered 1 time per day for 7 days with food (for short-term treatment) and 21 days (for long-term therapy).
To evaluate the morphological changes of the heart, kidneys and liver, we used frozen transverse sections, 10 µm thick, which were stained by the method of Ramonovsky-Gimze..
The results of the study. Corvitin when applying with ramipril and candesartan had a protective effect on the studied structures of target organs: myocardium of the ventricles, cortex of the kidney, hepatocytes. But Corvitin cardioprotective effect observed in myocardial tissue of the left ventricle during long-term combination therapy with candesartan was more significant and is characterized by the disappearance of signs of hydropic vacuolation of cardiomyocytes. Combination therapy with hypotensive drugs corvitin reduced degree of atrophy of the glomeruli, the greatest efficiency was achieved after long-term therapy. Changes in the liver tissue with the combination of drugs also had positive dynamics.
Conclusions. Combined therapy with antihypertensive drugs and corvitin significantly improves the morphological result in the studied structures not only by reducing blood pressure, but also by the pleiotropic effects of corvitin
References
- Barteková, M., Šimončíková, P., Fogarassyová, M., Ivanová, M., Okruhlicová, Ľ., Tribulová, N. et. al. (2015). Quercetin Improves Postischemic Recovery of Heart Function in Doxorubicin-Treated Rats and Prevents Doxorubicin-Induced Matrix Metalloproteinase-2 Activation and Apoptosis Induction. International Journal of Molecular Sciences, 16 (12), 8168–8185. doi: http://doi.org/10.3390/ijms16048168
- Sheik Uduman, M. S. T., Reddy, R. B., Punuru, P., Chakka, G., Karunakaran, G. (2016). Protective Role of Ramipril and Candesartan against Myocardial Ischemic Reperfusion Injury: A Biochemical and Transmission Electron Microscopical Study. Advances in Pharmacological Sciences, 2016, 1–7. doi: http://doi.org/10.1155/2016/4608979
- Gurevich, M. A., Kuzmenko, N. A. (2017). Porazhenie serdca pri arterialnoi gipertenzii. Metody vozdeistviia na gipertenziiu i sokratitelnuiu disfunkciiu. Consilium Medicum, 19 (1), 88–92.
- Fusi, F., Trezza, A., Tramaglino, M., Sgaragli, G., Saponara, S., Spiga, O. (2020). The beneficial health effects of flavonoids on the cardiovascular system: Focus on K+ channels. Pharmacological Research, 152, 104625. doi: http://doi.org/10.1016/j.phrs.2019.104625
- Zharynova, V. Yu., Parasiuk, E. Y., Samots, Y. A. (2016). Vozmozhnosty povishenyia effektyvnosty antyhypertenzyvnoi terapyy: rol donatorov oksyda azota. Zdorovia Ukrainy, 1 (44), 45–46.
- Tolparov, G. V. (2016) Vliianie blokatorov renin-angiotenzin-aldosteronovoi sistemy na funkcionalnoe sostoianie pravogo zheludochka pri infarkte miokarda perednei stenki levogo zheludochka. Kubanskii nauchnii medicinskii vestnik, 3 (158), 126–129.
- Zhuravleva, D. A. (2009). Modeli arterialnoi gipertenzii. Spontanno-gipertenzivnye krysy. Kunstkamera, 15 (6), 721–722.
- Bartekova, M., Radosinska, J., Pancza, D., Barancik, M., Ravingerova, T. (2016). Cardioprotective Effects of Quercetin Against Ischemia-Reperfusion Injury Are Age-Dependent. Physiological Research, 65 (1), 101–107. doi: http://doi.org/10.33549/physiolres.933390
- Mahalias, V. M., Mikhieiev, A. O., Rohovyi, Yu. Ye. et. al. (2001). Suchasni metody eksperymentalnykh ta klinichnykh doslidzhen tsentralnoi naukovo-doslidnoi laboratoriii Bukovynskoi derzhavnoi medychnoi akademii. Chernivtsi, 42.
- Moibenko, A. A., Parkhomenko, A. N. (2015). Effektivnost vodorastvorimoi formy kvercetina (Korvitina) pri lechenii ostrogo koronarnogo sindroma s elevaciei segmenta ST. Available at: http://health-ua.com/article/671.html
- Parkhomenko, A. N., Kozhukhov, S. N. (2014). Rezultaty otkrytogo randomizirovannogo issledovaniia po izucheniiu perenosimosti i effektivnosti preparata Korvitin u pacientov s zastoinoi serdechnoi nedostatochnostiu i sistolicheskoi disfunkciei levogo zheludochka. Ukrainskii medichnii chasopis, 4 (102), VII/VIII.
- Zemlyaniy, Y. V. (2014). Dynamics of structural and functional changes of the heart and the levels of GDF 15 and NTproBNP on the candesartan and ramipril therapy in patients with heart failure with preserved ejection fraction after myocardial infarction on the background of arter. Zaporozhye Medical Journal, 2, 13–17. doi: http://doi.org/10.14739/2310-1210.2014.2.25232
- Forner, D., Kulai, T., Arnason, T., Gruchy, E. S., MacLeod, M. (2017). Ramipril-associated cholestasis in the setting of recurrent drug-induced liver injury. Gastroenterol Hepatol Bed Bench, 10 (2), 143–146.
- Oyagbemi, A. A., Omobowale, T. O., Ola-Davies, O. E., Asenuga, E. R., Ajibade, T. O., Adejumobi, O. A. et. al. (2018). Quercetin attenuates hypertension induced by sodium fluoride via reduction in oxidative stress and modulation of HSP 70/ERK/PPARγ signaling pathways. BioFactors, 44 (5), 465–479. doi: http://doi.org/10.1002/biof.1445
- Chen, X., Li, H., Wang, Z., Zhou, Q., Chen, S., Yang, B. et. al. (2020). Quercetin protects the vascular endothelium against iron overload damages via ROS/ADMA/DDAHⅡ/eNOS/NO pathway. European Journal of Pharmacology, 868, 172885. doi: http://doi.org/10.1016/j.ejphar.2019.172885
- Gaponova, T. I., Kobeliackii, Iu. Iu., Panchenko, G. V. (2015). Rol korvitina i latrena v profilaktike i terapii reperfuzionnogo sindroma pri rekonstruktivnykh operaciiakh u pacientov s khronicheskoi ishemiei nizhnikh konechnostei. Medicina neotlozhnykh sostoianii, 2 (65), 88–92.
- Zhyliaiev, S. O., Shtryhol, S. Yu., Zhyliaev, S. A., Shtryhol, S. Yu. (2013). Tserebroprotektyvna aktyvnist korvitynu ta lipoflavonu pry kombinatsii hostroi alkoholnoi intoksykatsii ta cherepno-mozkovoi travmy v eksperymenti. Pytannia eksperymentalnoi ta klinichnoi medytsyny, 17 (1), 93–103.
- Douros, A., Kauffmann, W., Bronder, E., Klimpel, A., Garbe, E., Kreutz, R. (2013). Ramipril-Induced Liver Injury: Case Report and Review of the Literature. American Journal of Hypertension, 26 (9), 1070–1075. doi: http://doi.org/10.1093/ajh/hpt090
- Khanal, M. K., Dhungana, R. R., Bhandari, P., Gurung, Y., Paudel, K. N. (2017). Prevalence, associated factors, awareness, treatment, and control of hypertension: Findings from a cross sectional study conducted as a part of a community based intervention trial in Surkhet, Mid-western region of Nepal. PLOS ONE, 12 (10), e0185806. doi: http://doi.org/10.1371/journal.pone.0185806
- Vrolijk, M. F., Essen, H., Opperhuizen, A., Bast, A., Janssen, B. J. (2020). Haemodynamic effects of the flavonoid quercetin in rats revisited. British Journal of Pharmacology. doi: http://doi.org/10.1111/bph.14955
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Alena Marushchak, Yuriy Rogovyy, Valentyn Shvets, Volodymyr Doroshko, Tetiana Savchuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.